Health
The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation – EurekAlert
TLI-Gates MRI agreement advances evolution of synthetic lung surfactants to treat respiratory distress syndrome in premature infants in low- and middle-income countries….
-AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES-
LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News18 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General13 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’